Fatty Liver - 73 Studies Found

Completed : Obesity and Nonalcoholic Fatty Liver Disease
: Non-Alcoholic Fatty Liver Disease
: 2005-12-06
:
  • Drug: Niacin Subjects randomiz
Completed : The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease
: Non-alcoholic Fatty Liver Disease
: 2009-01-08
: Dietary Supplement: Efamax 5g daily as capsules for 3 months
Withdrawn : Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
: Non-Alcoholic Fatty Liver Disease
: 2009-07-15
:
  • Drug: Lovaza Approximately 50%
Completed : Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
: Nonalcoholic Fatty Liver Disease
: 2008-03-03
:
  • Behavioral: Life style intervention

Completed : Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
: Non-alcoholic Fatty Liver Disease
: 2013-12-04
:
  • Drug: Sillymarin Sillymarin is
Terminated : A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
: Non-alcoholic Fatty Liver Disease
: 2010-07-19
:
  • Drug: Mitoquinone mesylate 2 t
Completed : Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
: Non-alcoholic Fatty Liver Disease
: 2008-03-17
: Procedure: Phlebotomy Phlebotomy involves the removal of blood (approximately 500mL) each week until bod
Completed : Exercise Dose and Nonalcoholic Fatty Liver Disease
: Non-alcoholic Fatty Liver Disease (NAFLD)
: 2008-10-09
: Behavioral: exercise For 16 weeks subjects will exercise from 30-60 minutes five times a week.
Enrolling by invitation : Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
: Nonalcoholic Fatty Liver Disease
: 2009-09-22
Withdrawn : Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
: Non Alcoholic Fatty Liver Disease
: 2013-10-27
:
  • Drug: atorvastatin atorvastati
<<< Previous | Next >>>